|
1
|
Losser MR and Payen D: Mechanisms of liver
damage. Semin Liver Dis. 16:357–367. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Asrani SK, Devarbhavi H, Eaton J and
Kamath PS: Burden of liver diseases in the world. J Hepatol.
70:151–171. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Casey G: Diseases of the liver. Nurs N Z.
22:20–24. 2016.
|
|
4
|
Plotnikova OM and Skoblov MY: Efficiency
of the miRNA-mRNA interaction prediction programs. Mol Biol (Mosk).
52:543–554. 2018.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Q, Li T, Qi J, Liu J and Qin C: The
miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in
HBV-related hepatocellular carcinoma and promotes tumorigenesis and
tumor progression. PLoS One. 9:e1097822014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qi J, Qiao Y, Wang P, Li S, Zhao W and Gao
C: microRNA-210 negatively regulates LPS-induced production of
proinflammatory cytokines by targeting NF-κB1 in murine
macrophages. FEBS Lett. 586:1201–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chivukula RR, Shi G, Acharya A, Mills EW,
Zeitels LR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp
AC, et al: An essential mesenchymal function for miR-143/145 in
intestinal epithelial regeneration. Cell. 157:1104–1116. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bayraktar R and Van Roosbroeck K: miR-155
in cancer drug resistance and as target for miRNA-based
therapeutics. Cancer Metastasis Rev. 37:33–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Wei W, Cheng N, Wang K, Li B,
Jiang X and Sun S: Hepatitis C virus-induced up-regulation of
microRNA-155 promotes hepatocarcinogenesis by activating Wnt
signaling. Hepatology. 56:1631–1640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi Y, Li K, Xu K and Liu QH: MiR-155-5p
accelerates cerebral ischemia-reperfusion injury via targeting
DUSP14 by regulating NF-κB and MAPKs signaling pathways. Eur Rev
Med Pharmacol Sci. 24:1408–1419. 2020.PubMed/NCBI
|
|
12
|
Zhang Y, Xie Y, Zhang L and Zhao H:
MicroRNA-155 participates in smoke-inhalation-induced acute lung
injury through inhibition of SOCS-1. Molecules. 25:10222020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kandell WM, Donatelli SS, Trinh TL,
Calescibetta AR, So T, Tu N, Gilvary DL, Chen X, Cheng P, Adams WA,
et al: MicroRNA-155 governs SHIP-1 expression and localization in
NK cells and regulates subsequent infiltration into murine AT3
mammary carcinoma. PLoS One. 15:e02258202020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Quer J, Rodríguez-Frias F, Gregori J,
Tabernero D, Soria ME, García-Cehic D, Homs M, Bosch A, Pintó RM,
Esteban JI, et al: Deep sequencing in the management of hepatitis
virus infections. Virus Res. 239:115–125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Inoue J, Ninomiya M, Shimosegawa T and
McNiven MA: Cellular membrane trafficking machineries used by the
hepatitis viruses. Hepatology. 68:751–762. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Appourchaux K, Dokmak S, Resche-Rigon M,
Treton X, Lapalus M, Gattolliat CH, Porchet E, Martinot-Peignoux M,
Boyer N, Vidaud M, et al: MicroRNA-based diagnostic tools for
advanced fibrosis and cirrhosis in patients with chronic hepatitis
B and C. Sci Rep. 6:349352016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yugo DM, Hauck R, Shivaprasad HL and Meng
XJ: Hepatitis virus infections in poultry. Avian Dis. 60:576–588.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tong S and Revill P: Overview of hepatitis
B viral replication and genetic variability. J Hepatol. 64 (Suppl
1):S4–S16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sarkar N, Panigrahi R, Pal A, Biswas A,
Singh SP, Kar SK, Bandopadhyay M, Das D, Saha D, Kanda T, et al:
Expression of microRNA-155 correlates positively with the
expression of Toll-like receptor 7 and modulates hepatitis B virus
via C/EBP-β in hepatocytes. J Viral Hepat. 22:817–827. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su C, Hou Z, Zhang C, Tian Z and Zhang J:
Ectopic expression of microRNA-155 enhances innate antiviral
immunity against HBV infection in human hepatoma cells. Virol J.
8:3542011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen L, Ming X, Li W, Bi M, Yan B, Wang X,
Yang P and Yang B: The microRNA-155 mediates hepatitis B virus
replication by reinforcing SOCS1 signalling-induced autophagy. Cell
Biochem Funct. 38:436–442. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang W, Bian H, Li F, Li X, Zhang D, Sun
S, Song S, Zhu Q, Ren W, Qin C and Qi J: HBeAg induces the
expression of macrophage miR-155 to accelerate liver injury via
promoting production of inflammatory cytokines. Cell Mol Life Sci.
75:2627–2641. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zeisel MB, Felmlee DJ and Baumert TF:
Hepatitis C virus entry. Curr Top Microbiol Immunol. 369:87–112.
2013.PubMed/NCBI
|
|
24
|
Bala S, Tilahun Y, Taha O, Alao H, Kodys
K, Catalano D and Szabo G: Increased microRNA-155 expression in the
serum and peripheral monocytes in chronic HCV infection. J Transl
Med. 10:1512012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kałużna EM: MicroRNA-155 and
microRNA-196b: Promising biomarkers in hepatitis C virus infection?
Rev Med Virol. 24:169–185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grek M, Piekarska A, Bartkowiak J, Fendler
W, Kuydowicz J, Wroblewski P, Paradowski M and Sidorkiewicz M:
Coordinated increase of miRNA-155 and miRNA-196b expression
correlates with the detection of the antigenomic strand of
hepatitis C virus in peripheral blood mononuclear cells. Int J Mol
Med. 28:875–880. 2011.PubMed/NCBI
|
|
27
|
Jiang M, Broering R, Trippler M, Wu J,
Zhang E, Zhang X, Gerken G, Lu M and Schlaak JF: MicroRNA-155
controls Toll-like receptor 3- and hepatitis C virus-induced immune
responses in the liver. J Viral Hepat. 21:99–110. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng YQ, Ren JP, Zhao J, Wang JM, Zhou Y,
Li GY, Moorman JP and Yao ZQ: MicroRNA-155 regulates interferon-g
production in natural killer cells via Tim-3 signalling in chronic
hepatitis C virus infection. Immunology. 145:485–497. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McDaniel K, Herrera L, Zhou T, Francis H,
Han Y, Levine P, Lin E, Glaser S, Alpini G and Meng F: The
functional role of microRNAs in alcoholic liver injury. J Cell Mol
Med. 18:197–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park HK, Jo W, Choi HJ, Jang S, Ryu JE,
Lee HJ, Lee H, Kim H, Yu ES and Son WC: Time-course changes in the
expression levels of miR-122, −155, and −21 as markers of liver
cell damage, inflammation, and regeneration in
acetaminophen-induced liver injury in rats. J Vet Sci. 17:45–51.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Szabo G and Lippai D: Converging actions
of alcohol on liver and brain immune signaling. Int Rev Neurobiol.
118:359–380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bala S, Marcos M, Kodys K, Csak T,
Catalano D, Mandrekar P and Szabo G: Up-regulation of microRNA-155
in macrophages contributes to increased tumor necrosis factor
{alpha} (TNF{alpha}) production via increased mRNA half-life in
alcoholic liver disease. J Biol Chem. 286:1436–1444. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bala S and Szabo G: MicroRNA signature in
alcoholic liver disease. Int J Hepatol. 2012:4982322012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Babuta M, Furi I, Bala S, Bukong TN, Lowe
P, Catalano D, Calenda C, Kodys K and Szabo G: Dysregulated
autophagy and lysosome function are linked to exosome production by
Micro-RNA 155 in alcoholic liver disease. Hepatology. 70:2123–2141.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Katarey D and Verma S: Drug-induced liver
injury. Clin Med (Lond). 16 (Suppl 6):S104–S109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vinken M, Maes M, Vanhaecke T and Rogiers
V: Drug-induced liver injury: Mechanisms, types and biomarkers.
Curr Med Chem. 20:3011–3021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sutti S and Tacke F: Liver inflammation
and regeneration in drug-induced liver injury: Sex matters! Clin
Sci (Lond). 132:609–613. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yuan K, Zhang X, Lv L, Zhang J, Liang W
and Wang P: Fine-tuning the expression of microRNA-155 controls
acetaminophen-induced liver inflammation. Int Immunopharmacol.
40:339–346. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Glaziou P, Floyd K and Raviglione MC:
Global epidemiology of tuberculosis. Semin Respir Crit Care Med.
39:271–285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shih TY, Young TH, Lee HS, Hsieh CB and Hu
OY: Protective effects of kaempferol on isoniazid- and
rifampicin-induced hepatotoxicity. AAPS J. 15:753–762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Song L, Zhang Z, Zhang J, Zhu X, He L, Shi
Z, Gao L and Feng F: Ratio of microRNA-122/155 in isoniazid-induced
acute liver injury in mice. Exp Ther Med. 12:889–894. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tili E, Michaille JJ, Cimino A, Costinean
S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and
Croce CM: Modulation of miR-155 and miR-125b levels following
lipopolysaccharide/TNF-alpha stimulation and their possible roles
in regulating the response to endotoxin shock. J Immunol.
179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wan C, Han R, Liu L, Zhang F, Li F, Xiang
M and Ding W: Role of miR-155 in fluorooctane sulfonate-induced
oxidative hepatic damage via the Nrf2-dependent pathway. Toxicol
Appl Pharmacol. 295:85–93. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang L, Zhang N, Wang Z, Ai DM, Cao ZY and
Pan HP: Decreased MiR-155 level in the peripheral blood of
non-alcoholic fatty liver disease patients may serve as a biomarker
and may influence LXR activity. Cell Physiol Biochem. 39:2239–2248.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Neuschwander-Tetri BA: Non-alcoholic fatty
liver disease. BMC Med. 15:452017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bala S, Csak T, Saha B, Zatsiorsky J,
Kodys K, Catalano D, Satishchandran A and Szabo G: The
pro-inflammatory effects of miR-155 promote liver fibrosis and
alcohol-induced steatohepatitis. J Hepatol. 64:1378–1387. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Csak T, Bala S, Lippai D, Kodys K,
Catalano D, Iracheta-Vellve A and Szabo G: MicroRNA-155 deficiency
attenuates liver steatosis and fibrosis without reducing
inflammation in a mouse model of steatohepatitis. PLoS One.
10:e01292512015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lin X, Jia J, Du T, Li W, Wang X, Wei J,
Lin X, Zeng H, Yao L, Chen X, et al: Overexpression of miR-155 in
the liver of transgenic mice alters the expression profiling of
hepatic genes associated with lipid metabolism. PLoS One.
10:e01184172015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tsochatzis EA, Bosch J and Burroughs AK:
Liver cirrhosis. Lancet. 383:1749–1761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qiang H, Lin Y, Zhang X, Zeng X, Shi J,
Chen YX, Yang MF, Han ZG and Xie WF: Differential expression genes
analyzed by cDNA array in the regulation of rat hepatic
fibrogenesis. Liver Int. 26:1126–1137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pinzani M: Epithelial-mesenchymal
transition in chronic liver disease: Fibrogenesis or escape from
death? J Hepatol. 55:459–465. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dai W, Zhao J, Tang N, Zeng X, Wu K, Ye C,
Shi J, Lu C, Ning B, Zhang J and Lin Y: MicroRNA-155 attenuates
activation of hepatic stellate cell by simultaneously preventing
EMT process and ERK1 signalling pathway. Liver Int. 35:1234–1243.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Elbekai RH, Korashy HM and El-Kadi AO: The
effect of liver cirrhosis on the regulation and expression of drug
metabolizing enzymes. Curr Drug Metab. 5:157–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Vuppalanchi R, Liang T, Goswami CP,
Nalamasu R, Li L, Jones D, Wei R, Liu W, Sarasani V, Janga SC and
Chalasani N: Relationship between differential hepatic microRNA
expression and decreased hepatic cytochrome P450 3A activity in
cirrhosis. PLoS One. 8:e744712013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhai Y, Petrowsky H, Hong JC, Busuttil RW
and Kupiec-Weglinski JW: Ischaemia-reperfusion injury in liver
transplantation-from bench to bedside. Nat Rev Gastroenterol
Hepatol. 10:79–89. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tang B, Wang Z, Qi G, Yuan S, Yu S, Li B,
Wei Y, Huang Q, Zhai R and He S: MicroRNA-155 deficiency attenuates
ischemia-reperfusion injury after liver transplantation in mice.
Transpl Int. 28:751–760. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lentsch AB, Kato A, Yoshidome H, McMasters
KM and Edwards MJ: Inflammatory mechanisms and therapeutic
strategies for warm hepatic ischemia/reperfusion injury.
Hepatology. 32:169–173. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tan L, Jiang W, Lu A, Cai H and Kong L:
miR-155 aggravates liver ischemia/reperfusion injury by suppressing
SOCS1 in mice. Transplant Proc. 50:3831–3839. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li Y, Ma D, Wang Z and Yang J:
MicroRNA-155 deficiency in kupffer cells ameliorates liver
ischemia-reperfusion injury in mice. Transplantation.
101:1600–1608. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Perry BC, Soltys D, Toledo AH and
Toledo-Pereyra LH: Tumor necrosis factor-α in liver
ischemia/reperfusion injury. J Invest Surg. 24:178–188. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Xia G, Wu S, Wang X and Fu M: Inhibition
of microRNA-155 attenuates concanavalin-A-induced autoimmune
hepatitis by regulating Treg/Th17 cell differentiation. Can J
Physiol Pharmacol. 96:1293–1300. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Zachou K, Muratori P, Koukoulis GK,
Granito A, Gatselis N, Fabbri A, Dalekos GN and Muratori L: Review
article: Autoimmune hepatitis-current management and challenges.
Aliment Pharmacol Ther. 38:887–913. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Li A, Li J, Bao Y, Yuan D and Huang Z:
Xuebijing injection alleviates cytokine-induced inflammatory liver
injury in CLP-induced septic rats through induction of suppressor
of cytokine signaling 1. Exp Ther Med. 12:1531–1536. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chen YL, Xu G, Liang X, Wei J, Luo J, Chen
GN, Yan XD, Wen XP, Zhong M and Lv X: Inhibition of hepatic cells
pyroptosis attenuates CLP-induced acute liver injury. Am J Transl
Res. 8:5685–5695. 2016.PubMed/NCBI
|
|
65
|
Yang ZB, Chen WW, Chen HP, Cai SX, Lin JD
and Qiu LZ: MiR-155 aggravated septic liver injury by oxidative
stress-mediated ER stress and mitochondrial dysfunction via
targeting Nrf-2. Exp Mol Pathol. 105:387–394. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lv X, Zhang Y, Cui Y, Ren Y, Li R and Rong
Q: Inhibition of microRNA155 relieves sepsisinduced liver injury
through inactivating the JAK/STAT pathway. Mol Med Rep.
12:6013–6018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Li Z, Han S, Jia Y, Yang Y, Han F, Wu G,
Li X, Zhang W, Jia W, He X, et al: MCPIP1 regulates RORα expression
to protect against liver injury induced by lipopolysaccharide via
modulation of miR-155. J Cell Physiol. Feb 27–2019.(Epub ahead of
print). doi: 10.1002/jcp.28327.
|
|
68
|
Wang X and Ning Q: Immune mediated liver
failure. EXCLI J. 13:1131–1144. 2014.PubMed/NCBI
|
|
69
|
An F, Gong B, Wang H, Yu D, Zhao G, Lin L,
Tang W, Yu H, Bao S and Xie Q: miR-15b and miR-16 regulate TNF
mediated hepatocyte apoptosis via BCL2 in acute liver failure.
Apoptosis. 17:702–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Zhang G, Yan C, Chen D, Wu X, Zhang Y,
Zhan Q and An F: Up-regulation of miR-155 contributes to
TNF-mediated hepatocyte apoptosis in acute liver failure. Turk J
Gastroenterol. 30:475–484. 2019. View Article : Google Scholar : PubMed/NCBI
|
